Clinical Trial Update: A Clinical Study of CD19 Universal CAR-γδT Cells in Active Systemic Lupus Erythematosus [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes an ongoing Phase 1/Phase 2 study of CD19 universal CAR-γδT cells in patients with systemic lupus erythematosus, currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• CD19 Universal CAR-γδT Cells (CD19 universal CAR- gamma-delta T cells)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Systemic Lupus Erythematosus | Phase 1, Phase 2 | Status: RECRUITING